Elevai Labs, Inc. (ELAB)

Market Cap	12.15M
Revenue (ttm)	1.71M
Net Income (ttm)	-4.30M
Shares Out	17.33M
EPS (ttm)	-0.40
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	526,306
Open	0.710
Previous Close	0.705
Day's Range	0.630 - 0.719
52-Week Range	0.571 - 4.244
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 27, 2024

About ELAB

Elevai Labs Inc., a skincare development company, designs, manufactures, and markets skincare products in the United States. The company offers Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. It serves dermatologists, plastic surgeons, medical spa owners, and physicians focused on aesthetic and therapeutic skincare. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs Inc. was incorporated in 2020 and is based in...

• Industry: Biotechnology
• Sector: Healthcare
• IPO Date: Nov 21, 2023
• Employees: 18
• Stock Exchange: NASDAQ
• Ticker Symbol: ELAB

Financial Performance

In 2023, Elevai Labs's revenue was $1.71 million, an increase of 123.50% compared to the previous year's $766,277. Losses were -$4.30 million, 138.9% more than in 2022.